Simona Heidempergher
Direktor/Vorstandsmitglied bei THE EUROPEAN SMALLER COMPANIES TRUST PLC
Vermögen: 44 621 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Coen Teulings | M | - |
Merifin Europe SA
 Merifin Europe SA Investment ManagersFinance Merifin Europe SA (Merifin Capital) is an independent private investment group which was established in 1989. From its offices in Brussels, Geneva, New York and London, Merifin Capital invests in traditional and alternative asset classes. | 35 Jahre |
| Christopher Casey | M | 69 | 14 Jahre | |
| Alessandro Potestà | M | 56 |
Industrie Saleri Italo SpA
 Industrie Saleri Italo SpA Auto Parts: OEMProducer Manufacturing Industrie Saleri Italo SpA engages in the manufacture of water pumps and cooling systems for the automotive industry. Its products include mechanical water pumps, adjustable water pumps, water pumps with assembles modules, and electric water pumps. The company was founded in 1942 and is headquartered in Lumezzane, Italy. | 2 Jahre |
| Matteo Cosmi | M | - |
Industrie Saleri Italo SpA
Industrie Saleri Italo SpA Auto Parts: OEMProducer Manufacturing Industrie Saleri Italo SpA engages in the manufacture of water pumps and cooling systems for the automotive industry. Its products include mechanical water pumps, adjustable water pumps, water pumps with assembles modules, and electric water pumps. The company was founded in 1942 and is headquartered in Lumezzane, Italy. | 7 Jahre |
| Nadya Wells | F | 54 | 5 Jahre | |
| Francesco Maria Lavino | M | 51 |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | 3 Jahre |
| Elena Bruschi | F | - | 7 Jahre | |
| John H. Rex | M | - |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | - |
| Richard Lightowler | M | - | - | |
| Basilio Saleri | M | - |
Industrie Saleri Italo SpA
Industrie Saleri Italo SpA Auto Parts: OEMProducer Manufacturing Industrie Saleri Italo SpA engages in the manufacture of water pumps and cooling systems for the automotive industry. Its products include mechanical water pumps, adjustable water pumps, water pumps with assembles modules, and electric water pumps. The company was founded in 1942 and is headquartered in Lumezzane, Italy. | 11 Jahre |
| Theo Stokman | M | - |
Merifin Europe SA
Merifin Europe SA Investment ManagersFinance Merifin Europe SA (Merifin Capital) is an independent private investment group which was established in 1989. From its offices in Brussels, Geneva, New York and London, Merifin Capital invests in traditional and alternative asset classes. | 35 Jahre |
| Saiyed Mahmood | M | 48 |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | - |
| Maria Paola Clara | M | 59 | 6 Jahre | |
| Ann Grevelius | F | 58 | 5 Jahre | |
| Guillaume de Rham | M | - |
Merifin Europe SA
Merifin Europe SA Investment ManagersFinance Merifin Europe SA (Merifin Capital) is an independent private investment group which was established in 1989. From its offices in Brussels, Geneva, New York and London, Merifin Capital invests in traditional and alternative asset classes. | - |
| Nicolas Oltramare | M | 68 |
Stramongate SA
| - |
| Massimo Colli | M | 74 |
Industrie Saleri Italo SpA
Industrie Saleri Italo SpA Auto Parts: OEMProducer Manufacturing Industrie Saleri Italo SpA engages in the manufacture of water pumps and cooling systems for the automotive industry. Its products include mechanical water pumps, adjustable water pumps, water pumps with assembles modules, and electric water pumps. The company was founded in 1942 and is headquartered in Lumezzane, Italy. | - |
| Pietro Stella | M | 50 | 6 Jahre | |
| Christopher Wright | M | 67 |
Merifin Europe SA
Merifin Europe SA Investment ManagersFinance Merifin Europe SA (Merifin Capital) is an independent private investment group which was established in 1989. From its offices in Brussels, Geneva, New York and London, Merifin Capital invests in traditional and alternative asset classes. | 35 Jahre |
| David Alhadeff | M | 44 | 6 Jahre | |
| Olivier Uyttenhove | M | - |
Merifin Europe SA
Merifin Europe SA Investment ManagersFinance Merifin Europe SA (Merifin Capital) is an independent private investment group which was established in 1989. From its offices in Brussels, Geneva, New York and London, Merifin Capital invests in traditional and alternative asset classes. | 6 Jahre |
| Pascal Faivre | M | - |
Merifin Europe SA
Merifin Europe SA Investment ManagersFinance Merifin Europe SA (Merifin Capital) is an independent private investment group which was established in 1989. From its offices in Brussels, Geneva, New York and London, Merifin Capital invests in traditional and alternative asset classes. | 5 Jahre |
| Daniel Burgess | M | - | 5 Jahre | |
| Sergio Bona | M | - |
Industrie Saleri Italo SpA
Industrie Saleri Italo SpA Auto Parts: OEMProducer Manufacturing Industrie Saleri Italo SpA engages in the manufacture of water pumps and cooling systems for the automotive industry. Its products include mechanical water pumps, adjustable water pumps, water pumps with assembles modules, and electric water pumps. The company was founded in 1942 and is headquartered in Lumezzane, Italy. | - |
| Giorgio Garimberti | M | - |
Industrie Saleri Italo SpA
Industrie Saleri Italo SpA Auto Parts: OEMProducer Manufacturing Industrie Saleri Italo SpA engages in the manufacture of water pumps and cooling systems for the automotive industry. Its products include mechanical water pumps, adjustable water pumps, water pumps with assembles modules, and electric water pumps. The company was founded in 1942 and is headquartered in Lumezzane, Italy. | - |
| Wilhelm Becker | M | - |
Industrie Saleri Italo SpA
Industrie Saleri Italo SpA Auto Parts: OEMProducer Manufacturing Industrie Saleri Italo SpA engages in the manufacture of water pumps and cooling systems for the automotive industry. Its products include mechanical water pumps, adjustable water pumps, water pumps with assembles modules, and electric water pumps. The company was founded in 1942 and is headquartered in Lumezzane, Italy. | - |
| Karen LaRochelle | F | 57 |
Advent Life Sciences LLP
 Advent Life Sciences LLP BiotechnologyHealth Technology Part of Advent Venture Partners LLP, Advent Life Sciences LLP is a venture capital firm for visionary innovators. The company is based in London, UK. Advent Life Sciences has achieved its first discovery milestone in collaboration with Bristol Myers Squibb, and is focused on the journey from innovative science to an approved medicine or product. The British company has a history of delivering value and is one of the leading venture capital firms in the industry. | 4 Jahre |
| Camilla Soenderby | F | - |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | 3 Jahre |
| Anderson Timothy | M | - |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | - |
| Guido Tabellini | M | 68 |
University of Bocconi
| 30 Jahre |
| Laura Guazzoni | F | 59 |
University of Bocconi
| 30 Jahre |
| Jan H. Huysmans | M | - |
Merifin Europe SA
Merifin Europe SA Investment ManagersFinance Merifin Europe SA (Merifin Capital) is an independent private investment group which was established in 1989. From its offices in Brussels, Geneva, New York and London, Merifin Capital invests in traditional and alternative asset classes. | - |
| Sylvie Grégoire | M | 63 |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | - |
| William Salomon | M | 66 | - | |
| Alberto Bartoli | M | 63 |
Industrie Saleri Italo SpA
Industrie Saleri Italo SpA Auto Parts: OEMProducer Manufacturing Industrie Saleri Italo SpA engages in the manufacture of water pumps and cooling systems for the automotive industry. Its products include mechanical water pumps, adjustable water pumps, water pumps with assembles modules, and electric water pumps. The company was founded in 1942 and is headquartered in Lumezzane, Italy. | - |
| Naveed Iqbal Siddiqi | M | - |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | - |
| Alan Walts | M | 64 |
Advent Life Sciences LLP
Advent Life Sciences LLP BiotechnologyHealth Technology Part of Advent Venture Partners LLP, Advent Life Sciences LLP is a venture capital firm for visionary innovators. The company is based in London, UK. Advent Life Sciences has achieved its first discovery milestone in collaboration with Bristol Myers Squibb, and is focused on the journey from innovative science to an approved medicine or product. The British company has a history of delivering value and is one of the leading venture capital firms in the industry. | 10 Jahre |
| Ian James Nicholson | M | 64 |
Advent Life Sciences LLP
Advent Life Sciences LLP BiotechnologyHealth Technology Part of Advent Venture Partners LLP, Advent Life Sciences LLP is a venture capital firm for visionary innovators. The company is based in London, UK. Advent Life Sciences has achieved its first discovery milestone in collaboration with Bristol Myers Squibb, and is focused on the journey from innovative science to an approved medicine or product. The British company has a history of delivering value and is one of the leading venture capital firms in the industry. | 12 Jahre |
| Tony Kennedy | M | - |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | - |
| Severino Antonio Salvemini | M | 73 |
University of Bocconi
| 31 Jahre |
| Mohammed Malik | M | 56 |
Advent Life Sciences LLP
Advent Life Sciences LLP BiotechnologyHealth Technology Part of Advent Venture Partners LLP, Advent Life Sciences LLP is a venture capital firm for visionary innovators. The company is based in London, UK. Advent Life Sciences has achieved its first discovery milestone in collaboration with Bristol Myers Squibb, and is focused on the journey from innovative science to an approved medicine or product. The British company has a history of delivering value and is one of the leading venture capital firms in the industry. | 25 Jahre |
| Raj Bhikhu Parekh | M | 63 |
Advent Life Sciences LLP
Advent Life Sciences LLP BiotechnologyHealth Technology Part of Advent Venture Partners LLP, Advent Life Sciences LLP is a venture capital firm for visionary innovators. The company is based in London, UK. Advent Life Sciences has achieved its first discovery milestone in collaboration with Bristol Myers Squibb, and is focused on the journey from innovative science to an approved medicine or product. The British company has a history of delivering value and is one of the leading venture capital firms in the industry. | 19 Jahre |
| Jonathan Davie | M | 76 | 5 Jahre | |
| Mike Birch | M | - |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | - |
| Ralf Schmid | M | 57 |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | 8 Jahre |
| James Frederick William Williams | M | 58 | 1 Jahre | |
| Patrick Volkert Vink | M | 60 |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | 5 Jahre |
| Cengiz Selman | M | - |
Merifin Europe SA
Merifin Europe SA Investment ManagersFinance Merifin Europe SA (Merifin Capital) is an independent private investment group which was established in 1989. From its offices in Brussels, Geneva, New York and London, Merifin Capital invests in traditional and alternative asset classes. | 24 Jahre |
| Fiona MacLaughlin | M | - |
Advent Life Sciences LLP
Advent Life Sciences LLP BiotechnologyHealth Technology Part of Advent Venture Partners LLP, Advent Life Sciences LLP is a venture capital firm for visionary innovators. The company is based in London, UK. Advent Life Sciences has achieved its first discovery milestone in collaboration with Bristol Myers Squibb, and is focused on the journey from innovative science to an approved medicine or product. The British company has a history of delivering value and is one of the leading venture capital firms in the industry. | 12 Jahre |
| Anne Destoop | F | - |
Merifin Europe SA
Merifin Europe SA Investment ManagersFinance Merifin Europe SA (Merifin Capital) is an independent private investment group which was established in 1989. From its offices in Brussels, Geneva, New York and London, Merifin Capital invests in traditional and alternative asset classes. | - |
| Will West | M | - |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Rosina Tufnell | F | 60 | 2 Jahre | |
| Elena Cialliè | F | 56 |
University of Bocconi
| 4 Jahre |
| Alexander Mettenheimer | M | - | 11 Jahre | |
| Daniela Toscani | F | 60 | 2 Jahre | |
| Giovanna Zanotti | M | 52 |
University of Bocconi
| 8 Jahre |
| Giampaolo Provaggi | M | 61 | 1 Jahre | |
| Andrew Smith | M | 72 | 13 Jahre | |
| Christian Saverio Parth | M | - |
University of Bocconi
| 5 Jahre |
| Maria Alessandra Zunino de Pignier | F | 72 | 2 Jahre | |
| Paolo Ciccarelli | M | 65 | 1 Jahre | |
| Maurizio Sansone | M | - |
University of Bocconi
| 5 Jahre |
| Audley Twiston-Davies | M | 73 | 19 Jahre | |
| Roberto Antonio Enzo Deambrogio | M | 49 |
University of Bocconi
| 5 Jahre |
| Andrew Cecchini | M | - |
University of Bocconi
| 5 Jahre |
| Alessandro Baroni | M | 49 |
University of Bocconi
| 5 Jahre |
| Davide Guzzi | M | - |
University of Bocconi
| 6 Jahre |
| Susanna Priori | F | 55 |
University of Bocconi
| 4 Jahre |
| Laura Tardino | F | - |
University of Bocconi
| 5 Jahre |
| Luigi Feola | M | 56 |
University of Bocconi
| 2 Jahre |
| Sandro Moretti | M | - |
University of Bocconi
| 5 Jahre |
| Carlo Mazzola | M | - |
University of Bocconi
| 6 Jahre |
| Barbara Biassoni | F | 51 |
University of Bocconi
| 4 Jahre |
| Matteo Cerri | M | 50 |
University of Bocconi
| 4 Jahre |
| Alberto Acqua | M | 48 |
University of Bocconi
| 4 Jahre |
| Stefania Bertolini | F | 55 |
University of Bocconi
| 4 Jahre |
| Vincenzo Cariello | M | 58 |
University of Bocconi
| 1 Jahre |
| Renato Cerioli | M | - |
University of Bocconi
| 5 Jahre |
| Andrea Bardavid | M | 53 |
University of Bocconi
| 4 Jahre |
| Jonathan Buoni | M | - |
University of Bocconi
| 2 Jahre |
| Virginie Sarah S. Morgon | F | 54 |
University of Bocconi
| 1 Jahre |
| Enrico Vitali | M | 51 |
University of Bocconi
| 4 Jahre |
| Matteo Facoetti | M | 50 |
University of Bocconi
| 6 Jahre |
| Luca Maria Ravano | M | - |
University of Bocconi
| 5 Jahre |
| Anna Gatti | M | 52 |
University of Bocconi
| 4 Jahre |
| Valentina Franceschini | F | 49 |
University of Bocconi
| 5 Jahre |
| Alessio Manigrasso | M | - |
University of Bocconi
| 6 Jahre |
| Patrick Pircher | M | 50 |
University of Bocconi
| 8 Jahre |
| Marco Zampetti | M | 54 |
University of Bocconi
| 4 Jahre |
| Elisa Corghi | F | 51 |
University of Bocconi
| 5 Jahre |
| Marco Pompignoli | M | 57 |
University of Bocconi
| 4 Jahre |
| Sara Ghisalberti | F | - |
University of Bocconi
| 4 Jahre |
| Pietro Lorenzo Romani Adami | M | 57 |
University of Bocconi
| 5 Jahre |
| Pietro Paparoni | M | - |
University of Bocconi
| 5 Jahre |
| Marcello Massinelli | M | 52 |
University of Bocconi
| 4 Jahre |
| Andrea Novarese | M | 55 |
University of Bocconi
| 4 Jahre |
| Pietro Luigi Longo | M | 51 |
University of Bocconi
| 4 Jahre |
| Luca Naseddu | M | - |
University of Bocconi
| 6 Jahre |
| Raffaela Tommaselli | F | - |
University of Bocconi
| 4 Jahre |
| Daniele Guerini | M | - |
University of Bocconi
| 6 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Italien | 60 | 60,00% |
| Vereinigtes Königreich | 26 | 26,00% |
| Belgien | 9 | 9,00% |
| Bermuda | 4 | 4,00% |
| Luxemburg | 1 | 1,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Simona Heidempergher
- Persönliches Netzwerk
